Clinical and laboratory characteristics of AS activity at baseline and week 52, n=30
| Baseline | Week 52 | p | |
|---|---|---|---|
| Pain, Me [Q25;Q75] | 6.0 [7.0; 9.0] | 3.4 [1.0; 5.0] | <0.000 |
| BASDAI, Me [Q25;Q75] | 6.6 [4.4; 8.85] | 3.2 [2.1; 7.6] | <0.000 |
| ASDAS, Me [Q25;Q75] | 3.8 [3.5; 4.4] | 2.1 [1.26; 4.26] | <0.000 |
| C-RP, mg/l, M±SD | 12.3±3.9 | 4.3±1.7 | <0.000 |
| TNF α, pg/ml, M±SD | 17.8±7.6 | 7.3±3.2 | <0.000 |
| IL-17A, pg/ml, M±SD | 28.4±14.4 | 32.1±12.2 | 0.29 |